Literature DB >> 27379917

An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.

Domenico G Della Rocca1, Bradley J Willenberg2, Yanfei Qi1, Chelsey S Simmons3, Andres Rubiano3, Leonardo F Ferreira4, Tianyao Huo5, John W Petersen1, Prashant J Ruchaya6, Prateek S Wate2, Elizabeth A Wise7, Eileen M Handberg1, Christopher R Cogle7, Christopher D Batich2, Barry J Byrne8, Carl J Pepine9.   

Abstract

BACKGROUND: A new post-myocardial infarction (MI) therapy is injection of high-water-content polymeric biomaterial gels (hydrogels) into damaged myocardium to modulate cardiac negative remodeling and preserve heart function.
METHODS: We investigated the therapeutic potential of a novel gelatinized alginate hydrogel with a unique microstructure of uniform capillary-like channels (termed Capgel). Shortly (48h) after induced anterior MI, Sprague Dawley rats received intramyocardial injection of Capgel directly into the antero-septal wall at the infarct border zone (n=12) or no injection (n=10, controls). Echocardiograms were performed at 48h (week 0) and 4weeks (week 4) to evaluate left ventricular function.
RESULTS: Echocardiograms showed 27% improvement of left ventricular systolic function over time with gel injection: fractional shortening increased from 26±3% at week 0 to 33±2% at week 4 (p=0.001). Capgel was present at the injection site after 4weeks, but was minimal at 8weeks. The remaining gel was heavily populated by CD68(+) macrophages with CD206(+) clusters and blood vessels. An in vitro experiment was performed to assess Angiotensin-(1-7) released from Capgel. Angiotensin-(1-7) was released from the Capgel in a sustained manner for 90days.
CONCLUSIONS: Use of Capgel, a degradable, bioactive hydrogel composed of gelatinized capillary-alginate gel, appears safe for intramyocardial injection, is associated with improved left ventricular function after MI in rats, and may provide a long-term supply of Angiotensin-(1-7).
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Capillary-like channels; Gelatinized alginate hydrogel; Myocardial infarction

Mesh:

Substances:

Year:  2016        PMID: 27379917      PMCID: PMC4983460          DOI: 10.1016/j.ijcard.2016.06.158

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  23 in total

1.  Self-assembled copper-capillary alginate gel scaffolds with oligochitosan support embryonic stem cell growth.

Authors:  Bradley J Willenberg; Takashi Hamazaki; Fan-Wei Meng; Naohiro Terada; Christopher Batich
Journal:  J Biomed Mater Res A       Date:  2006-11       Impact factor: 4.396

2.  Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.

Authors:  Yanfei Qi; Juan Zhang; Colleen T Cole-Jeffrey; Vinayak Shenoy; Andrew Espejo; Mina Hanna; Chunjuan Song; Carl J Pepine; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2013-08-19       Impact factor: 10.190

3.  A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction.

Authors:  Domenico G Della Rocca; Bradley J Willenberg; Leonardo F Ferreira; Prateek S Wate; John W Petersen; Eileen M Handberg; Tong Zheng; Dennis A Steindler; Naohiro Terada; Christopher D Batich; Barry J Byrne; Carl J Pepine
Journal:  Med Hypotheses       Date:  2012-08-28       Impact factor: 1.538

4.  Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.

Authors:  Jennifer M Singelyn; Priya Sundaramurthy; Todd D Johnson; Pamela J Schup-Magoffin; Diane P Hu; Denver M Faulk; Jean Wang; Kristine M Mayle; Kendra Bartels; Michael Salvatore; Adam M Kinsey; Anthony N Demaria; Nabil Dib; Karen L Christman
Journal:  J Am Coll Cardiol       Date:  2012-02-21       Impact factor: 24.094

5.  Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.

Authors:  YanFei Qi; Vinayak Shenoy; Fong Wong; Hongwei Li; Aqeela Afzal; J Mocco; Colin Sumners; Mohan K Raizada; Michael J Katovich
Journal:  Exp Physiol       Date:  2011-06-17       Impact factor: 2.969

6.  Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating.

Authors:  Adam J Engler; Christine Carag-Krieger; Colin P Johnson; Matthew Raab; Hsin-Yao Tang; David W Speicher; Joseph W Sanger; Jean M Sanger; Dennis E Discher
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

7.  Influence of substrate stiffness on the phenotype of heart cells.

Authors:  Bashir Bhana; Rohin K Iyer; Wen Li Kelly Chen; Ruogang Zhao; Krista L Sider; Morakot Likhitpanichkul; Craig A Simmons; Milica Radisic
Journal:  Biotechnol Bioeng       Date:  2010-04-15       Impact factor: 4.530

8.  Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.

Authors:  Wangde Dai; Paul Gerczuk; Yuanyuan Zhang; Leona Smith; Oleg Kopyov; Gregory L Kay; Aarne J Jyrala; Robert A Kloner
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-01-22       Impact factor: 2.457

9.  A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.

Authors:  Sunil V Rao; Uwe Zeymer; Pamela S Douglas; Hussein Al-Khalidi; Jingyu Liu; C Michael Gibson; Robert W Harrison; Diane S Joseph; Reinilde Heyrman; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2015-08-24       Impact factor: 4.749

10.  Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction.

Authors:  Karen L Christman; Hubert H Fok; Richard E Sievers; Qizhi Fang; Randall J Lee
Journal:  Tissue Eng       Date:  2004 Mar-Apr
View more
  8 in total

Review 1.  Ventricular wall biomaterial injection therapy after myocardial infarction: Advances in material design, mechanistic insight and early clinical experiences.

Authors:  Yang Zhu; Yasumoto Matsumura; William R Wagner
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

2.  Transforming Capillary Alginate Gel (Capgel) into New 3D-Printing Biomaterial Inks.

Authors:  Andrew Philip Panarello; Corey Edward Seavey; Mona Doshi; Andrew K Dickerson; Thomas J Kean; Bradley Jay Willenberg
Journal:  Gels       Date:  2022-06-14

Review 3.  A deep dive into the darning effects of biomaterials in infarct myocardium: current advances and future perspectives.

Authors:  Thiagarajan Hemalatha; Mayilvahanan Aarthy; Suryalakshmi Pandurangan; Numbi Ramudu Kamini; Niraikulam Ayyadurai
Journal:  Heart Fail Rev       Date:  2021-08-03       Impact factor: 4.654

Review 4.  Biologics and their delivery systems: Trends in myocardial infarction.

Authors:  Matthew A Borrelli; Heth R Turnquist; Steven R Little
Journal:  Adv Drug Deliv Rev       Date:  2021-03-26       Impact factor: 17.873

Review 5.  Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration.

Authors:  Adegbenro Omotuyi John Fakoya; David Adeiza Otohinoyi; Joshua Yusuf
Journal:  Stem Cells Int       Date:  2018-04-29       Impact factor: 5.443

Review 6.  Therapeutic Acellular Scaffolds for Limiting Left Ventricular Remodelling-Current Status and Future Directions.

Authors:  Sadia Perveen; Daniela Rossin; Emanuela Vitale; Rachele Rosso; Roberto Vanni; Caterina Cristallini; Raffaella Rastaldo; Claudia Giachino
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

Review 7.  Alginate and alginate composites for biomedical applications.

Authors:  Raha Ahmad Raus; Wan Mohd Fazli Wan Nawawi; Ricca Rahman Nasaruddin
Journal:  Asian J Pharm Sci       Date:  2020-11-05       Impact factor: 6.598

Review 8.  Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases.

Authors:  Xiaoshan Liao; Xushan Yang; Hong Deng; Yuting Hao; Lianzhi Mao; Rongjun Zhang; Wenzhen Liao; Miaomiao Yuan
Journal:  Front Bioeng Biotechnol       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.